Detection of sentinel lymph nodes using radioactive isotope in skin cancer - Sentinel lymph node detection using radioisotopes in skin cancer

Fujiwara Masao0 sites104 target enrollmentOctober 25, 2018

Conditionsmetastatic skin cancer

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: metastatic skin cancer
Sponsor: Fujiwara Masao
Enrollment: 104
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

Sentinel lymph node (SLN) retrieval using radioisotopes was an effective and safe method. Lymphatic transit rate (LTR) values of metastatic lymph nodes were significantly higher than those of non-metastatic SLNs at all sites, and low LTR values suggested the possibility of negative nodes. A cutoff value was proposed as a guide for negative metastasis.

Registry

who.int

Start Date

October 25, 2018

End Date

January 31, 2020

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Fujiwara Masao

Eligibility Criteria

Inclusion Criteria

•1\. Patients who were diagnosed with metastatic skin cancer based on histopathological examination.
•2\. From the results of medical history, physical findings, blood, examination, and urine test, the patients who had no serious complications that could not put them under general anesthesia or lumbar anesthesia.
•3\. Patients who gave written informed consent.

Exclusion Criteria

•1\. Patients who are pregnant. Patients who are breast\-feeding. Patients with drug allergy to Technetium\-99m
•2\. Patients who did not give written informed consent.
•3\. Attending physician judged that the patients were inappropriate to participate in the study.